EMA’s Data Protection Notice for the exchange of information during the Critical Medicines Vulnerability Assessment exercise

The European Medicines Agency (EMA) has published a Data Protection Notice explaining the details of the processing of personal data by the EMA in the context of the exchange of information between Marketing Authorisation Holders and the EMA during the Critical Medicines Vulnerability Assessment exercise.